Bayesian methods for instrumental variable analysis with genetic instruments (‘Mendelian randomization’): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome
Open Access
- 25 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 39 (3) , 907-918
Abstract
The ‘Mendelian randomization’ approach uses genotype as an instrumental variable to distinguish between causal and non-causal explanations of biomarker–disease associations. Classical methods for instrumental variable analysis are limited to linear or probit models without latent variables or missing data, rely on asymptotic approximations that are not valid for weak instruments and focus on estimation rather than hypothesis testing. We describe a Bayesian approach that overcomes these limitations, using the JAGS program to compute the log-likelihood ratio (lod score) between causal and non-causal explanations of a biomarker–disease association. To demonstrate the approach, we examined the relationship of plasma urate levels to metabolic syndrome in the ORCADES study of a Scottish population isolate, using genotype at six single-nucleotide polymorphisms in the urate transporter gene SLC2A9 as an instrumental variable. In models that allow for intra-individual variability in urate levels, the lod score favouring a non-causal over a causal explanation was 2.34. In models that do not allow for intra-individual variability, the weight of evidence against a causal explanation was weaker (lod score 1.38). We demonstrate the ability to test one of the key assumptions of instrumental variable analysis—that the effects of the instrument on outcome are mediated only through the intermediate variable—by constructing a test for residual effects of genotype on outcome, similar to the tests of ‘overidentifying restrictions’ developed for classical instrumental variable analysis. The Bayesian approach described here is flexible enough to deal with any instrumental variable problem, and does not rely on asymptotic approximations that may not be valid for weak instruments. The approach can easily be extended to combine information from different study designs. Statistical power calculations show that instrumental variable analysis with genetic instruments will typically require combining information from moderately large cohort and cross-sectional studies of biomarkers with information from very large genetic case–control studies.Keywords
This publication has 47 references indexed in Scilit:
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- A variant associated with nicotine dependence, lung cancer and peripheral arterial diseaseNature, 2008
- ‘Mendelian randomization’ equals instrumental variable analysis with genetic instrumentsStatistics in Medicine, 2008
- Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and DyslipidemiaThe American Journal of Human Genetics, 2008
- Genomewide Rapid Association Using Mixed Model and Regression: A Fast and Simple Method For Genomewide Pedigree-Based Quantitative Trait Loci Association AnalysisGenetics, 2007
- Variational Bayesian learning of directed graphical models with hidden variablesBayesian Analysis, 2006
- Bayesian auxiliary variable models for binary and multinomial regressionBayesian Analysis, 2006
- Population Structure and EigenanalysisPLOS Genetics, 2006
- On the Foundations of Statistical InferenceJournal of the American Statistical Association, 1962
- XV.—The Correlation between Relatives on the Supposition of Mendelian Inheritance.Transactions of the Royal Society of Edinburgh, 1919